Skip to content

Biogen BIIB Income Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$2.48B+8.7%$2.28B-10.1%$2.53B-4.2%$2.65B+8.8%$2.43B-1.0%
$661M+33.4%$495.5M-26.5%$674.4M+11.5%$605M-3.9%$629.3M+7.8%
$1.82B+1.8%$1.78B-4.1%$1.86B-8.8%$2.04B+13.3%$1.8B-3.7%
73.3%-4.9pp78.3%+4.9pp73.4%-3.7pp77.1%+3.0pp74.1%-2.1pp
$539M+5.8%$509.4M+16.8%$436.1M+9.3%$399M-8.1%$434.1M-15.4%
$607.3M-11.0%$682.5M+14.7%$594.8M+1.9%$583.8M+2.0%$572.5M-15.8%
$2.1B-10.1%$2.34B+18.1%$1.98B+4.0%$1.9B-10.3%$2.12B-2.0%
$67.6M$67.4M-7.2%$72.6M+21.0%$60M
-$1.1M+99.7%-$317.6M-2,110%$15.8M+579%-$3.3M-232%$2.5M+101%
$377.7M$0-100%$557.3M-25.1%$744M+139%$311.2M+6.8%
$58.2M$0-100%$90.8M-16.8%$109.2M+54.5%$70.7M+185%
$319.5M$0-100%$466.5M-26.5%$634.8M+164%$240.5M-9.8%
12.9%+12.9pp0%-18.4pp18.4%-5.6pp24%+14.1pp9.9%-1.0pp
$2.15$0.00-100%$3.17-26.8%$4.33+164%$1.64-10.4%
$649.7M+225%$200.2M-75.8%$826.9M-18.2%$1.01B+82.3%$554.4M+16.6%
26.2%+17.4pp8.8%-23.8pp32.6%-5.6pp38.2%+15.4pp22.8%+3.4pp
$445.3M$0-100%$624.7M-23.5%$816.6M+120%$371.2M+27.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Biogen's revenue?
Biogen (BIIB) generated $9.9B in revenue over the trailing twelve months, up 1.2% year over year.
Is Biogen profitable?
Biogen reported $1.4B in net income over the trailing twelve months, a 14.3% net margin.
What are Biogen's profit margins?
Gross margin is 75.5% and operating margin is 22.9%, with a 14.3% net margin.
What is Biogen's earnings per share?
Biogen's diluted EPS over the trailing twelve months is $9.65.
Where does Biogen's income statement data come from?
Every line is extracted from Biogen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.